Not long ago we judged many healthcare interventions only in terms of their impact on survival. Today's clinical trials, however, will often assess quality of life during survival: even if survival is unaltered, quality of life may improve (or worsen). Such outcome measures are certainly desirable, but quality of life assessment is an immature science. Present methods are imperfect and often complex, and as a result they are often poorly applied in trials. Therefore, Quality of Life Assessment in Clinical Trials will be a useful resource for those undertaking or appraising trials. This is not a manual for the development and use of quality of life instruments. Rather, it is a collection of eighteen essays on different aspects of the use of such instruments in trials. The book is loosely divided into five sections primary issues, decision theory and preference assessment, psychometry, data analysis, and reporting results. In general the editors have been successful in commissioning chapters on the main issues, but there is occasional duplication, and a preface that outlined the book's structure would have been helpful. In addition, the level of previous understanding required varies between chapters. These defects, however, are not fundamental: I know of few other books that deal with the subject in such detail, and it contains some gems: a lucid chapter on crosscultural issues contains sound advice on issues that have too often been ignored in the past; another provides a clear but detailed introduction to decision analysis; another is the best introduction to factor analysis that I have read. Other chapters address the challenge of missing data, introduce Q-TWIST methods and give down-to-earth advice about presenting findings in graphical form. In the future, when I am taking part in the design or conduct of clinical trials, I will repeatedly return to this book for advice.
Of course, some issues remain unresolved. Quality of life measures are a crude method for summarizing the feelings, thoughts and symptoms of groups of individuals. They tend to make the dangerous assumption that quality of life for one person is much the same as it is for another. The most complex chapters are those that examine these matters and discuss the concepts of preferences and utilities. Although they provide ideas, they do not offer solutions. The cover promises that this hardback, one of the series of International Research Monographs in the Addictions will be an important resource for clinicians, researchers and policy makers. It is divided into two sections of six chapters each: the first covers the background to the cannabis problem, reviews the published work and examines the evidence for cannabis causing brain damage; the second describes the author's own work with event-related potentials to explore the question of whether cannabis causes cognitive impairment.
The first section is necessarily dated, in that research into the effects of cannabis peaked in the 1 970s and results were often inconclusive. I found this section difficult to read since it is essentially a catalogue of previous, often obscure, studies with an American bias. The research described looks at the acute and chronic effects of cannabis use particularly on attention and memory. Some interesting areas are ventured into, however the effects on infants of in-utero exposure to cannabis, comparisons of cannabis and alcohol induced intoxication and the existence of natural cannabinoids and their receptors with a possible link to chocolate addiction.
Section 2 begins with a detailed account of the author's own work and goes on to explore the question of whether there is evidence for cognitive impairment in long-term users of cannabis. The studies are on small numbers of volunteers and controls. Solowij presents evidence of impairment in cognitive processing (particularly of attention) in long-term cannabis users, proposes possible mechanisms for these effects and endeavours to explain other findings such as impairments being greater in those with a lower IQ, why some long-term cannabis users seem to adapt and show less impairment than medium-term users and why subtle cognitive impairments do not necessarily translate into real-life impairments in, for example, driving. This section is much more user-friendly in that the methodology is explained and each chapter concludes with a key point summary.
This book is best viewed as a well researched resource. In the concluding chapters I had the feeling that the author wished to nail her colours to the mast and state categorically that long-term cannabis use does cause harm but could not escape from the laboratory setting and project her findings into 'real life'. The discussion does not really enter into the political or social arena and is therefore limited to advancing scientific explanations for the findings described and making suggestions for future research. More questions are raised
